BUY Aurobindo Pharma — Kunal Saraogi, 06 Jul 2026

BUYAurobindo Pharma

Aurobindo Pharma share price target & all analyst calls

byKunal SaraogiHorizon: Swing (≤2wk)6 Jul 2026via Zee Business (Live)

Entry₹1,615Stated

Target₹1,680

Total upside +4.02%

Stop loss₹1,590-1.55% risk

Exit₹1,5906 Jul 2026, 3:15 pm

Stop-loss hit-1.55%

Follow Kunal Saraogi for new calls(35% target hit, 52 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 1 active Swing call on AUROPHARMA See 142 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:46 pm IST

5 supporting0 opposing

Supports the BUY call (5)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·3 Jul · 3d ago

Aurobindo Pharma USA Inc., a subsidiary of Aurobindo Pharma, has completed the acquisition of Lannett.

NSE · Acquisition·30 Jun · 6d ago

Aurobindo Pharma Ltd has announced the completion of an acquisition.

BSE · Company Update·25 Jun · 1w ago

Aurobindo Pharma has completed the execution of a solar power purchase agreement and acquired a 26% stake in Swarnaakshu Solar Power Private Limited for Rs. 52 lakhs. The company plans further investm

NSE · Acquisition·25 Jun · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·6 Apr · 3mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Kunal Saraogi

Every call and its outcome